Vivos Therapeutics (VVOS) Total Debt Growth (1y) (2020 - 2021)

Vivos Therapeutics (VVOS) Total Debt Growth (1y) (2020 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 157.11%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -12.26%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -1.95%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -2.48%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 0.12%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 19.06%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -5.76%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -2.49%
10 Vivos Therapeutics 3.62 Mn 1.38 Mn 3.06 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2021 -1.94%
Dec 31, 2020 -65.22%